Diagnostic Medical Systems Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Samuel Sancerni
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.5yrs |
| CEO ownership | 2.0% |
| Management average tenure | no data |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Diagnostic Medical Systems (EPA:ALDMS) Use Debt?
Dec 07
Potential Upside For Diagnostic Medical Systems S.A. (EPA:ALDMS) Not Without Risk
Oct 10Potential Upside For Diagnostic Medical Systems S.A. (EPA:ALDMS) Not Without Risk
Apr 20Does Diagnostic Medical Systems (EPA:ALDMS) Have A Healthy Balance Sheet?
Dec 08Diagnostic Medical Systems S.A. (EPA:ALDMS) Stock Catapults 32% Though Its Price And Business Still Lag The Industry
Jun 09Is Diagnostic Medical Systems (EPA:ALDMS) Weighed On By Its Debt Load?
Oct 28Is Diagnostic Medical Systems (EPA:ALDMS) Using Debt In A Risky Way?
Jun 17Diagnostic Medical Systems (EPA:DGM) Has Debt But No Earnings; Should You Worry?
Nov 18Does Diagnostic Medical Systems (EPA:DGM) Have A Healthy Balance Sheet?
Jun 04What Can We Make Of Diagnostic Medical Systems' (EPA:DGM) CEO Compensation?
Dec 22CEO
Samuel Sancerni
2.5yrs
Tenure
€141,289
Compensation
Mr. Samuel Sancerni serves as Chief Executive Officer of European Medical Solutions (Formerly, DMS Imaging Group) since September 12, 2022 and serves as its Director. He is Chairman & CEO of Diagnostic Med...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 2.5yrs | €141.29k | 2% € 271.9k | |
| Director | 2.5yrs | no data | 1.38% € 187.5k | |
| Director | no data | no data | no data | |
| Director | 1.5yrs | no data | no data | |
| Director | 1.5yrs | no data | no data |
2.0yrs
Average Tenure
Experienced Board: ALDMS's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/01 16:59 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Diagnostic Medical Systems S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|